phase trial (subgroup of trial) → CapableOf → evaluate cndo-109-activated allogeneic natural killer
Typicality: 0.250
Saliency: 0.000
Facets 0
No facets.
Open triples 1
phase trial → evaluate → cndo-109-activated allogeneic natural killer 3
Sentiment analysis
negative neutral positive
0.196 0.780 0.024
Other statistics
Raw frequency 3
Normalized frequency 0.000
Modifier score 0.500
Perplexity 204.948